COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II) : a prospective cohort study
Citation
Agrawal , U , Katikireddi , S V , McCowan , C , Mulholland , R H , Azcoaga-Lorenzo , A , Amele , S , Fagbamigbe , A F , Vasileiou , E , Grange , Z , Shi , T , Kerr , S , Moore , E , Murray , J L K , Shah , S A , Ritchie , L , O'Reilly , D , Stock , S J , Beggs , J , Chuter , A , Torabi , F , Akbari , A , Bedston , S , McMenamin , J , Wood , R , Tang , R S M , de Lusignan , S , Hobbs , F D R , Woolhouse , M , Simpson , C R , Robertson , C & Sheikh , A 2021 , ' COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II) : a prospective cohort study ' , The Lancet Respiratory Medicine , vol. 9 , no. 12 , pp. 1439-1449 . https://doi.org/10.1016/S2213-2600(21)00380-5
Rights
Under a Creative Commons license https://creativecommons.org/licenses/by/4.0/